These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 30195794)

  • 1. A Novel Mechanism of Doxorubicin Resistance and Tumorigenesis Mediated by MicroRNA-501-5p-Suppressed BLID.
    Xu YC; Liu X; Li M; Li Y; Li CY; Lu Y; Sanches J; Wang L; Du Y; Mao LM; Zuo SB; Liu HT; Shen J; Wang B; Hou L; Li LH; Tang JW; Ju JF; Guan HW; Song B
    Mol Ther Nucleic Acids; 2018 Sep; 12():578-590. PubMed ID: 30195794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomal transfer of miR-501 confers doxorubicin resistance and tumorigenesis via targeting of BLID in gastric cancer.
    Liu X; Lu Y; Xu Y; Hou S; Huang J; Wang B; Zhao J; Xia S; Fan S; Yu X; Du Y; Hou L; Li Z; Ding Z; An S; Huang B; Li L; Tang J; Ju J; Guan H; Song B
    Cancer Lett; 2019 Sep; 459():122-134. PubMed ID: 31173853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-362-5p enhances the cisplatin sensitivity of gastric cancer cells by targeting suppressor of zeste 12 protein.
    Wei X; Gao M; Ahmed Y; Gao M; Liu W; Zhang Y; Xie X; Zhao Q; Wang H; Gu K
    Oncol Lett; 2019 Aug; 18(2):1607-1616. PubMed ID: 31423228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rosmarinic acid reduces the resistance of gastric carcinoma cells to 5-fluorouracil by downregulating FOXO4-targeting miR-6785-5p.
    Yu C; Chen DQ; Liu HX; Li WB; Lu JW; Feng JF
    Biomed Pharmacother; 2019 Jan; 109():2327-2334. PubMed ID: 30551491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of microRNA-17-5p inhibits drug resistance of gastric cancer cells partially through targeting p21.
    Wang Z; Ji F
    Oncol Lett; 2018 Apr; 15(4):4585-4591. PubMed ID: 29541229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-129-5p inhibits proliferation of gastric cancer cells through targeted inhibition on HMGB1 expression.
    Feng J; Guo J; Wang JP; Chai BF
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3665-3673. PubMed ID: 32329842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circular RNA circVAPA promotes chemotherapy drug resistance in gastric cancer progression by regulating miR-125b-5p/STAT3 axis.
    Deng P; Sun M; Zhao WY; Hou B; Li K; Zhang T; Gu F
    World J Gastroenterol; 2021 Feb; 27(6):487-500. PubMed ID: 33642823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miRNA expression patterns in chemoresistant breast cancer tissues.
    Lv J; Xia K; Xu P; Sun E; Ma J; Gao S; Zhou Q; Zhang M; Wang F; Chen F; Zhou P; Fu Z; Xie H
    Biomed Pharmacother; 2014 Oct; 68(8):935-42. PubMed ID: 25451164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA 494 increases chemosensitivity to doxorubicin in gastric cancer cells by targeting phosphodiesterases 4D.
    Peng QP; Du DB; Ming Q; Hu F; Wu ZB; Qiu S
    Cell Mol Biol (Noisy-le-grand); 2018 Dec; 64(15):62-66. PubMed ID: 30672438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Honokiol antagonizes doxorubicin resistance in human breast cancer via miR-188-5p/FBXW7/c-Myc pathway.
    Yi X; Lou L; Wang J; Xiong J; Zhou S
    Cancer Chemother Pharmacol; 2021 May; 87(5):647-656. PubMed ID: 33544209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-192-5p reverses cisplatin resistance by targeting ERCC3 and ERCC4 in SGC7901/DDP cells.
    Xie X; Huang N; Zhang Y; Wei X; Gao M; Li M; Ning J; Liu W; Zhao Q; Wang H; Gu K
    J Cancer; 2019; 10(4):1039-1051. PubMed ID: 30854110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells.
    Xia L; Zhang D; Du R; Pan Y; Zhao L; Sun S; Hong L; Liu J; Fan D
    Int J Cancer; 2008 Jul; 123(2):372-379. PubMed ID: 18449891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-96 expression induced by low-dose cisplatin or doxorubicin regulates chemosensitivity, cell death and proliferation in gastric cancer SGC7901 cells by targeting FOXO1.
    Lang C; Xu M; Zhao Z; Chen J; Zhang L
    Oncol Lett; 2018 Sep; 16(3):4020-4026. PubMed ID: 30128023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of microRNA-524-5p enhances the cisplatin sensitivity of gastric cancer cells by modulating proliferation and metastasis via targeting SOX9.
    Wang J; Xue X; Hong H; Qin M; Zhou J; Sun Q; Liang H; Gao L
    Oncotarget; 2017 Jan; 8(1):574-582. PubMed ID: 27880941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-30a-5p inhibits the proliferation and invasion of gastric cancer cells by targeting insulin-like growth factor 1 receptor.
    Liu Y; Zhou Y; Gong X; Zhang C
    Exp Ther Med; 2017 Jul; 14(1):173-180. PubMed ID: 28672911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia-inducible microRNA-224 promotes the cell growth, migration and invasion by directly targeting RASSF8 in gastric cancer.
    He C; Wang L; Zhang J; Xu H
    Mol Cancer; 2017 Feb; 16(1):35. PubMed ID: 28173803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-219-5p Represses the Proliferation, Migration, and Invasion of Gastric Cancer Cells by Targeting the LRH-1/Wnt/β-Catenin Signaling Pathway.
    Li C; Dong J; Han Z; Zhang K
    Oncol Res; 2017 Apr; 25(4):617-627. PubMed ID: 27983934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-575 targets BLID to promote growth and invasion of non-small cell lung cancer cells.
    Wang H; Yan C; Shi X; Zheng J; Deng L; Yang L; Yu F; Yang Y; Shao Y
    FEBS Lett; 2015 Mar; 589(7):805-11. PubMed ID: 25728273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-126 increases chemosensitivity in drug-resistant gastric cancer cells by targeting EZH2.
    Wang P; Li Z; Liu H; Zhou D; Fu A; Zhang E
    Biochem Biophys Res Commun; 2016 Oct; 479(1):91-6. PubMed ID: 27622325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miRNA-192-5p impacts the sensitivity of breast cancer cells to doxorubicin via targeting peptidylprolyl isomerase A.
    Zhang Y; He Y; Lu LL; Zhou ZY; Wan NB; Li GP; He X; Deng HW
    Kaohsiung J Med Sci; 2019 Jan; 35(1):17-23. PubMed ID: 30844143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.